Latest News

Simbec-Orion and biotx.ai launch strategic partnership to de-risk early-stage drug development with AI supported clinical trial design.

26/10/2023

PRESS RELEASE: 26 October 2023 Simbec-Orion, a full-service mid-size CRO, and biotx.ai, a developer of AI-enabled causal modelling for drug development, have announced their strategic partnership to bring AI-powered insights and predictive models to support data-driven clinical trial design. Simbec-Orion, a specialist in oncology, rare disease, and clinical pharmacology studies, has over 45 years’ experience […]

Read More

Oxford Cannabinoid Technology partners with Simbec-Onion on milestone FIH Phase I study

10/10/2023

Simbec-Orion is honoured to have been trusted by Oxford Cannabinoid Technologies to run this milestone first-in-human Phase1 clinical trial of its lead compound, OCT461201 for Postherpetic Neuralgia (PHN) & Irritable Bowel Syndrome. Chief Scientific Officer, Valentino Parravicini recently discussed the significance of partnering with Simbec-Orion for the first-in-human Phase 1 clinical trial of the lead compound, […]

Read More

Simbec-Orion Expands Immunoassay Capability

19/07/2023

In line with our continuing investment in technology, we have recently expanded our immunoassay capability with the addition of a second Ella™ ELISA analyser from ProteinSimple. Utilising Simple PlexTM technology, EllaTM is providing Simbec-Orion clients with access to an extensive library of key immunoassays to support the measurement of both the immunogenic potential and pharmacodynamic […]

Read More

Simbec-Orion to conduct a Phase II clinical trial in pulmonary sarcoidosis patients for Molecure’s OATD-01

18/07/2023

Warsaw, 3rd July 2023 Molecure has signed an agreement to conduct a Phase II clinical trial for its lead molecule OATD-01, taking another important step in the development of this program. Read the full press release here

Read More

Welcome to Simon Jennings

05/07/2023

We are delighted to share that Simon Jennings as joined Simbec-Orion as Vice President, Data Sciences. Simon has over 35 years in the pharmaceutical and CRO industry comprising a variety of global leadership roles in Biostatistics, Data Management, Statistical Programming and Biometrics Project Management covering all phases of clinical research in Glaxo, Celltech, Eisai, Sandoz/Novartis […]

Read More

Le groupe Simbec-Orion a reçu l’accréditation pour la taxe Recherche & Développement

27/06/2023

Le groupe Simbec-Orion a reçu l’accréditation pour la taxe Recherche & Développement ‹‹CIR – Crédit d’Impôt Recherche›› qui donne droit aux entreprises françaises qui sont assujetties à l’impôt sur les sociétés en France, la capacité de réclamer un allégement fiscal sur les coûts générés pour des activités concernant la Recherche & Développement externalisée par le […]

Read More

Steering Your Path to the Clinic, Complimentary Breakfast Workshop, June 29, Oxford UK

07/06/2023

How confident are you in your route to the clinic?  There are multiple hurdles to be navigated, many of which can knock your development programme off course and threaten that all-important milestone. Optimising your clinical study design, so that it delivers the endpoints you need, without wasting time and budget, is crucial to keeping your […]

Read More

Got a question?
Get in Touch or Submit an RFI/RFP

Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email enrolmentservices@simbecorion.com

Follow us on Social Media

Name(Required)
Opt In Emails